Acquired Amegakaryocytic Thrombocytopenia
1 clinical trials · Condition
◉ Watch Acquired Amegakaryocytic Thrombocytopenia
| Record | Firm | Date |
|---|---|---|
| MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. (NCT06412497) | Masonic Cancer Center, University of Minnesota | 2024-06-05 |
Track Acquired Amegakaryocytic Thrombocytopenia automatically
Every clearance here is in the API, with alerts when new ones post.